George L. King

44.8k total citations · 12 hit papers
276 papers, 32.5k citations indexed

About

George L. King is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, George L. King has authored 276 papers receiving a total of 32.5k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Molecular Biology, 74 papers in Endocrinology, Diabetes and Metabolism and 68 papers in Physiology. Recurrent topics in George L. King's work include Retinal Diseases and Treatments (55 papers), Metabolism, Diabetes, and Cancer (40 papers) and Advanced Glycation End Products research (30 papers). George L. King is often cited by papers focused on Retinal Diseases and Treatments (55 papers), Metabolism, Diabetes, and Cancer (40 papers) and Advanced Glycation End Products research (30 papers). George L. King collaborates with scholars based in United States, Japan and Canada. George L. King's co-authors include Lloyd Paul Aiello, Christian Rask‐Madsen, Pedro Geraldes, Edward P. Feener, C. Ronald Kahn, Napoleone Ferrara, Daisuke Koya, Allen C. Clermont, Toyoshi Inoguchi and Kerrie J. Way and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

George L. King

272 papers receiving 31.5k citations

Hit Papers

Vascular Endothelial Growth Factor in Ocular Fluid of Pat... 1985 2026 1998 2012 1994 1995 2004 2001 2010 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
    1994 3.0k citations Lloyd Paul Aiello, George L. King et al. profile →
  2. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
    1995 1.0k citations Lloyd Paul Aiello, George L. King et al. profile →
  3. Retinopathy in Diabetes
    2004 813 citations Lloyd Paul Aiello, George L. King et al. Diabetes Care profile →
  4. The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO-MCBN, the American Diabetes Association and the German Diabetes Society
    2001 763 citations George L. King et al. profile →
  5. Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
    2010 720 citations Pedro Geraldes, George L. King profile →
  6. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.
    1992 631 citations George L. King et al. profile →
  7. Vascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
    2013 624 citations Christian Rask‐Madsen, George L. King profile →
  8. The Role of Inflammatory Cytokines in Diabetes and Its Complications
    2008 533 citations George L. King profile →
  9. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
    1999 524 citations George L. King et al. Diabetes profile →
  10. Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor
    1997 515 citations Lloyd Paul Aiello, Allen C. Clermont et al. Diabetes profile →
  11. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta.
    1985 364 citations George L. King, C. Ronald Kahn et al. Journal of Clinical Investigation profile →
  12. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
    2017 359 citations George L. King et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George L. King United States 90 12.6k 7.3k 7.0k 6.3k 4.9k 276 32.5k
Michael Brownlee United States 58 9.7k 0.8× 10.5k 1.4× 2.3k 0.3× 8.5k 1.4× 3.7k 0.7× 106 35.1k
Mark E. Cooper Australia 109 11.6k 0.9× 17.9k 2.4× 1.4k 0.2× 5.4k 0.9× 12.7k 2.6× 514 48.8k
Sho‐ichi Yamagishi Japan 80 6.0k 0.5× 7.8k 1.1× 1.6k 0.2× 3.8k 0.6× 2.7k 0.6× 449 23.2k
Rafael Simó Spain 68 5.0k 0.4× 4.1k 0.6× 7.1k 1.0× 1.8k 0.3× 972 0.2× 418 17.5k
Alicia J. Jenkins Australia 61 2.8k 0.2× 5.0k 0.7× 2.5k 0.4× 1.7k 0.3× 1.9k 0.4× 420 14.4k
Ann Marie Schmidt United States 113 13.3k 1.1× 11.7k 1.6× 1.1k 0.2× 9.7k 1.5× 3.6k 0.7× 395 49.7k
Peter P. Nawroth Germany 95 9.8k 0.8× 5.1k 0.7× 632 0.1× 6.4k 1.0× 2.7k 0.6× 494 36.3k
Timothy J. Lyons United States 65 3.2k 0.3× 3.9k 0.5× 1.8k 0.3× 1.9k 0.3× 1.1k 0.2× 223 14.7k
Per‐Henrik Groop Finland 74 5.8k 0.5× 9.8k 1.3× 656 0.1× 4.2k 0.7× 3.7k 0.8× 522 23.0k
James K. Liao United States 96 11.5k 0.9× 4.5k 0.6× 581 0.1× 6.4k 1.0× 7.1k 1.4× 280 35.1k

Countries citing papers authored by George L. King

Since Specialization
Citations

This map shows the geographic impact of George L. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George L. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George L. King more than expected).

Fields of papers citing papers by George L. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George L. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George L. King. The network helps show where George L. King may publish in the future.

Co-authorship network of co-authors of George L. King

This figure shows the co-authorship network connecting the top 25 collaborators of George L. King. A scholar is included among the top collaborators of George L. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George L. King. George L. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Li, Satoru Onizuka, Kyoungmin Park, et al.. (2025). Differential Effects of Retinol-Binding Protein 3 and Anti-VEGF Antibodies on Retinal Dysfunctions in Diabetic Retinopathy. Diabetes. 74(5). 787–797. 2 indexed citations
2.
Hanlon, J. E., Mustafa Ünal, Daniel J. Brooks, et al.. (2025). Effect of type 1 and type 2 diabetes on human femoral trabecular bone composition, microarchitecture, and mechanical behavior. Bone. 200. 117588–117588.
3.
Shinjo, Takanori, Satoru Onizuka, Atsushi Ishikado, et al.. (2023). Dysregulation of CXCL1 Expression and Neutrophil Recruitment in Insulin Resistance and Diabetes-Related Periodontitis in Male Mice. Diabetes. 72(7). 986–998. 26 indexed citations
4.
Rathjen, Thomas, Britta Kunkemoeller, Carly Cederquist, et al.. (2022). Endothelial Cell Insulin Signaling Regulates CXCR4 (C-X-C Motif Chemokine Receptor 4) and Limits Leukocyte Adhesion to Endothelium. Arteriosclerosis Thrombosis and Vascular Biology. 42(7). e217–e227. 7 indexed citations
5.
Fu, Jialin, Marc Gregory Yu, Qian Li, Kyoungmin Park, & George L. King. (2021). Insulin's actions on vascular tissues: Physiological effects and pathophysiological contributions to vascular complications of diabetes. Molecular Metabolism. 52. 101236–101236. 55 indexed citations
6.
Fickweiler, Ward, Samantha M. Paniagua, Marc Gregory Yu, et al.. (2020). Association of Cognitive Function and Retinal Neural and Vascular Structure in Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 106(4). e1139–e1149. 14 indexed citations
7.
Vaisar, Tomáš, Jenny E. Kanter, Jake Wimberger, et al.. (2019). High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes. Diabetes Care. 43(1). 178–186. 46 indexed citations
8.
King, George L., Marguerite J. McNeely, Lorna E. Thorpe, et al.. (2012). Understanding and Addressing Unique Needs of Diabetes in Asian Americans, Native Hawaiians, and Pacific Islanders. Diabetes Care. 35(5). 1181–1188. 106 indexed citations
9.
Bézy, Olivier, Thien T. Tran, Jussi Pihlajamäki, et al.. (2011). PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. Journal of Clinical Investigation. 121(6). 2504–2517. 115 indexed citations
10.
Jeong, In‐Kyung & George L. King. (2011). New Perspectives on Diabetic Vascular Complications: The Loss of Endogenous Protective Factors Induced by Hyperglycemia. Diabetes & Metabolism Journal. 35(1). 8–8. 33 indexed citations
11.
Keenan, Hillary A., Jennifer K. Sun, Alessandro Doria, et al.. (2010). Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study. Diabetes. 59(11). 2846–2853. 382 indexed citations
12.
Geraldes, Pedro, Kunimasa Yagi, Yuzuru Ohshiro, et al.. (2008). Selective Regulation of Heme Oxygenase-1 Expression and Function by Insulin through IRS1/Phosphoinositide 3-Kinase/Akt-2 Pathway. Journal of Biological Chemistry. 283(49). 34327–34336. 60 indexed citations
13.
Sun, Jennifer K., Hillary A. Keenan, Jerry D. Cavallerano, Lloyd Paul Aiello, & George L. King. (2006). Ocular Characteristics and Retinopathy Risk Factors in Patients With 50 Years or More of Type 1 Diabetes Mellitus. Investigative Ophthalmology & Visual Science. 47(13). 1020–1020.
14.
He, Zhiheng, et al.. (2005). Molecular Targets of Diabetic Cardiovascular Complications. Current Drug Targets. 6(4). 487–494. 65 indexed citations
15.
Timothy, Nigel H., et al.. (2004). d––Tocopherol Reduces Diabetes–Induced Retinal Vascular Leakage and ERG Abnormalities in the Rat. Investigative Ophthalmology & Visual Science. 45(13). 1099–1099. 1 indexed citations
16.
Way, Kerrie J., et al.. (2001). Protein kinase C and the development of diabetic vascular complications. Diabetic Medicine. 18(12). 945–959. 238 indexed citations
17.
Suzuma, Kiyoshi, Keiko Naruse, Izumi Suzuma, et al.. (2000). Vascular Endothelial Growth Factor Induces Expression of Connective Tissue Growth Factor via KDR, Flt1, and Phosphatidylinositol 3-Kinase-Akt-dependent Pathways in Retinal Vascular Cells. Journal of Biological Chemistry. 275(52). 40725–40731. 218 indexed citations
18.
Wakasaki, Hisao, et al.. (1998). Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Journal of Molecular and Cellular Cardiology. 30(6). 15. 12 indexed citations
19.
Nishio, Yoshihiko, Charles E. Warren, Jo Ann Buczek‐Thomas, et al.. (1995). Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue.. Journal of Clinical Investigation. 96(4). 1759–1767. 51 indexed citations
20.
King, George L., et al.. (1985). Processing and transport of insulin by vascular endothelial cells. The American Journal of Medicine. 79(3). 43–47. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Brownlee Breakdown of academic impact, for papers by Mark E. Cooper Breakdown of academic impact, for papers by Sho‐ichi Yamagishi Breakdown of academic impact, for papers by Rafael Simó Breakdown of academic impact, for papers by Alicia J. Jenkins Breakdown of academic impact, for papers by Ann Marie Schmidt Breakdown of academic impact, for papers by Peter P. Nawroth Breakdown of academic impact, for papers by Timothy J. Lyons Breakdown of academic impact, for papers by Per‐Henrik Groop Breakdown of academic impact, for papers by James K. Liao
Rankless by CCL
2026